Investigation of Injury Risk and Related Factors in Adolescent Male Soccer Players

September 21, 2026 updated by: Gulsah Bargi, Izmir Democracy University

Investigation of the Relationship Between Injury Risk and Muscle Strength, Functional Performance, and Balance in Adolescent Male Soccer Players.

The aim of this study is to examine the relationship between injury risk and muscle strength, functional performance, and balance in adolescent male soccer players.

Study Overview

Status

Not yet recruiting

Detailed Description

This study aims to examine the relationship between injury risk and muscle strength, functional performance, and balance in adolescent male soccer players. Accordingly, potential relationships between these variables will be analyzed by investigating whether the players' physical characteristics influence injury risk.

Study Type

Observational

Enrollment (Estimated)

44

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Alperen Binici

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Our study includes a single research group consisting of healthy adolescent footballers who have been playing football for at least one year.

Description

Inclusion Criteria:

  • Being between the ages of 10 and 19
  • Having played football for at least one year
  • Having sustained an injury resulting in an absence from the field for more than one week during the four months prior to the study

Exclusion Criteria:

  • Having any health issue or injury at the time of testing
  • Having any health problem that could prevent the measurements required for the study from being taken
  • Having a history of injury within the last four months that could hinder the performance of the measurements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: CASE_ONLY
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Footballers

This group will consist of active footballers competing at the regional or national level.

Injury risk, cough and abdominal muscle strength, functional performance, and balance status of the football players will be evaluated.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury risc assessment
Time Frame: through study completion, an average of 1 year

The Functional Movement Screening Test will be used to assess injury risc in athletes. Seven exercises are used in this test. Each movement is scored on a scale from 0 to 3, with a maximum total score of 21. As the score from this test increases, the risk of injury decreases.

through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cough Strength Measurement
Time Frame: through study completion, an average of 1 year

Cough force will be assessed using a peak flow meter. The highest value of three attempts will be recorded. The high value obtained indicates good cough strength.

through study completion, an average of 1 year
measurement of abdominal muscle strength
Time Frame: through study completion, an average of 1 year

It will be measured using the sit-up test; abdominal muscle strength increases as the number of sit-ups increases.

through study completion, an average of 1 year
Functional Performance Assessment
Time Frame: through study completion, an average of 1 year

The squat jump will be assessed using the device.

through study completion, an average of 1 year
Balance evaluation
Time Frame: through study completion, an average of 1 year

Balance will be assessed using the Y-Balance Test, and the average distance reached will be recorded.

through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ALPEREN BİNİCİ, Izmir Democracy University
  • Study Director: GÜLŞAH BARĞI, Assoc Prof, Izmir Democracy University
  • Principal Investigator: RÜMEYSA BİNİCİ, Izmir Democracy University
  • Principal Investigator: MESUT BUĞDAY, Izmir Democracy University
  • Principal Investigator: Efe Yusuf AYAR, Göztepe Sports Club
  • Principal Investigator: FERRUH TAŞPINAR, Izmir Democracy University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 15, 2026

Primary Completion (Estimated)

April 30, 2028

Study Completion (Estimated)

April 30, 2028

Study Registration Dates

First Submitted

September 21, 2026

First Submitted That Met QC Criteria

September 21, 2026

First Posted (Actual)

September 28, 2026

Study Record Updates

Last Update Posted (Actual)

September 28, 2026

Last Update Submitted That Met QC Criteria

September 21, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe